IBM Hyper Protect Accelerator is an investment-readiness and technical mentorship program, run in partnership with Village Capital and IBM. The program supports impact-focused startups leveraging highly sensitive data to improve the quality of, and access to digital, financial and healthcare services and is currently accepting applications. No equity is taken by IBM or Village Capital as part of the program.
This year the program will expand to support more companies working on impactful datatech products. The 2021 program will consist of three components:
- The IBM Hyper Protect Accelerator (15 companies): 2 years of technical mentorship from IBM (including up to $120,000 of free IBM cloud credits) & a 3 month intensive Village Capital Investment Readiness Accelerator with bespoke mentor and investor matching.
- Friends of Hyper Protect (40 companies): 2 years of quarterly technical mentorship from IBM (including up to $120,000 of free IBM cloud credits) & a 3-month Investment Readiness support fromVillage Capital focusing on milestone planning and investor matchmaking.
- The Datatech for Good Coalition: A coalition on Village Capital’s Abaca platform that matches datatech for good startups with like-minded investors and peers.
Previous femtech and female-led healthtech companies, who have participated in the program include:
- My Normative (Canada / Proof of Concept / B2C / Healthtech): “The only health tracking app available in North America that incorporates female-specific metrics into their wearable health and fitness tracking app.”
- Renalis (USA / Proof of Concept / B2B / Healthtech): “Creating digital therapeutics in pelvic health, initially focused on persons identified as female at birth, but eventually expanding to all persons with a pelvis”
- Consentic (Australia / Generally Available / B2B / Healthtech): “Optimizes, standardizes, and streamlines medical consent, resulting in enhanced patient understanding, improved patient and clinician satisfaction, and increased efficiency.”
Applications for this 4th cohort close on June 30th, 2021.